Institutional investors purchased a net $1.9 million shares of SRPT during the quarter ended June 2017, and now own 68.22% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MILLENNIUM MANAGEMENT LLC Bought 1.2 Million shares of Sarepta Therapeutics Inc
POINT72 ASSET MANAGEMENT LP Bought 1.2 Million shares of Sarepta Therapeutics Inc